Cargando…

Clostridium difficile-associated diarrhea following the therapy with antibiotic and proton pump inhibitors in a 77-year-old man with several comorbidities: A case report

RATIONALE: Clostridium difficile-associated diarrhea (CDAD) remains a persistent challenge, with substantially increased incidence and severity. The rising burden of CDAD requires urgent identification of preventable risk factors. PATIENTS CONCERNS: A 77-year-old man with the symptoms of abdominal p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Xiaoqun, Zhang, Jun, Jiang, Miao, Liu, Yujuan, Ren, Weifang, Fang, Zhonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455990/ https://www.ncbi.nlm.nih.gov/pubmed/30921218 http://dx.doi.org/10.1097/MD.0000000000015004

Ejemplares similares

Clostridium difficile and Antibiotic-associated Diarrhea
por: Bhattacharyya, Mahuya, et al.
Publicado: (2020)

Antibiotic-Associated Diarrhea: Candidate Organisms other than Clostridium Difficile
por: Song, Hyun Joo, et al.
Publicado: (2008)

Proton pump inhibitors and the incidence of Clostridium difficile on the intensive care unit
por: Whitehead, I, et al.
Publicado: (2007)

The Positive Association between Proton Pump Inhibitors and Clostridium Difficile Infection
por: Tawam, Dania, et al.
Publicado: (2021)

Relationship between diarrhea and Clostridium difficile
por: Laza, Ruxandra, et al.
Publicado: (2013)

Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection
por: Inghammar, Malin, et al.
Publicado: (2021)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

Fluoroquinolone Use and Clostridium difficile–Associated Diarrhea
por: McCusker, Margaret E., et al.
Publicado: (2003)

Clostridium difficile-associated diarrhea in dialysis patients()
por: Eui Oh, Sook, et al.
Publicado: (2013)

Lactulose may reduce Clostridium difficile‐related diarrhea among patients receiving antibiotics
por: Maltz, Charles, et al.
Publicado: (2020)

Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment
por: Bradley, Evan Stuart, et al.
Publicado: (2019)

515. Estimating the Effect of Proton Pump Inhibitor Stewardship in Reducing Clostridium difficile Transmission
por: Lofgren, Eric, et al.
Publicado: (2018)

Clostridium difficile infection in children hospitalized due to diarrhea
por: Dulęba, K., et al.
Publicado: (2013)

Clostridium difficile in patients with nosocomial diarrhea, Northwest of Iran
por: Hematyar, Yalda, et al.
Publicado: (2020)

Risk Factors Associated With Clostridium difficile-Associated Diarrhea
por: Gupta, Aarzoo, et al.
Publicado: (2021)

Do Probiotics Prevent Clostridium difficile-Associated Diarrhea?
por: Al Sharaby, Afrah, et al.
Publicado: (2022)

Emerging Insights into Antibiotic-Associated Diarrhea and Clostridium difficile Infection through the Lens of Microbial Ecology
por: Walk, Seth T., et al.
Publicado: (2008)

Clinical and microbial characterization of toxigenic Clostridium difficile isolated from antibiotic associated diarrhea in Egypt
por: Elgendy, Sherein G., et al.
Publicado: (2020)

Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients
por: Pohl, John F., et al.
Publicado: (2011)

Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
por: Trifan, Anca, et al.
Publicado: (2017)

Effects of β-Lactam Antibiotics and Fluoroquinolones on Human Gut Microbiota in Relation to Clostridium difficile Associated Diarrhea
por: Knecht, Henrik, et al.
Publicado: (2014)

Clostridium difficile in faeces from healthy dogs and dogs with diarrhea
por: Wetterwik, Karl-Johan, et al.
Publicado: (2013)

Genes Encoding Toxin of Clostridium difficile in Children with and without Diarrhea
por: Merino, Victor R. C., et al.
Publicado: (2014)

Cost analysis of hospitalized Clostridium difficile-associated diarrhea (CDAD)
por: Hübner, Claudia, et al.
Publicado: (2015)

Fidaxomicin Use and Clinical Outcomes for Clostridium difficile–Associated Diarrhea
por: Eiland, Edward H., et al.
Publicado: (2015)

Prevention of Clostridium difficile Infection and Associated Diarrhea: An Unsolved Problem
por: Principi, Nicola, et al.
Publicado: (2020)

Antibiotics Associated With Clostridium difficile Infection
por: Rafey, Abdur, et al.
Publicado: (2023)

Effect of a Probiotic on Prevention of Diarrhea and Clostridium difficile and Clostridium perfringens Shedding in Foals
por: Schoster, A., et al.
Publicado: (2015)

Recurrence and death after Clostridium difficile infection: gender-dependant influence of proton pump inhibitor therapy
por: Dos Santos-Schaller, Ophélie, et al.
Publicado: (2016)

Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
por: Seto, Charlie T, et al.
Publicado: (2014)

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
por: Barletta, Jeffrey F, et al.
Publicado: (2014)

Proton Pump Inhibitors and Clostridium Difficile Infection: Are We Propagating an Already Rapidly Growing Healthcare Problem?
por: Patil, Rashmee, et al.
Publicado: (2013)

Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile
por: Alberda, Cathy, et al.
Publicado: (2018)

Erratum to: Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility
por: Seto, Charlie T., et al.
Publicado: (2016)

Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
por: Min, Jung Hwa, et al.
Publicado: (2016)

Factors associated with Clostridium difficile diarrhea in a hospital in Beijing, China
por: Lv, Z., et al.
Publicado: (2014)

Laboratory Experience with the Liaison Analyzer in the Diagnosis of Clostridium Difficile-Associated Diarrhea
por: Benedek, Orsolya, et al.
Publicado: (2016)

Ribotypes Matter, Significance of Clostridium difficile Ribotypes in Cancer Patients with Diarrhea
por: Guevara, Eduardo Yepez, et al.
Publicado: (2017)

1673 Microbial and Inflammatory Markers for Fatal Clostridium difficile Associated Diarrhea
por: Jiang, Zhi-Dong, et al.
Publicado: (2014)

Risk Factors of Patients With Diarrhea for Having Clostridioides (Clostridium) difficile Infection
por: Lang, Vanessa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6iam16q1g6jm9rhb9b47a5atl6